日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Phase II study of induction cisplatin and irinotecan followed by concurrent carboplatin, etoposide, and thoracic radiotherapy for limited-stage small-cell lung cancer, CALGB 30206

CALGB 30206 是一项针对局限期小细胞肺癌的 II 期研究，评估了顺铂和伊立替康诱导化疗后序贯卡铂、依托泊苷和胸部放疗的疗效。

期刊:Journal of Thoracic Oncology
影响因子:20.8
doi:10.1097/JTO.0b013e31827628e1
Kelley, Michael J; Bogart, Jeffrey A; Hodgson, Lydia D; Ansari, Rafat H; Atkins, James N; Pang, Herbert; Green, Mark R; Vokes, Everett E
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2013
文献求助 收藏

Physician preferences for management of patients with stage IIIA NSCLC: impact of bulk of nodal disease on therapy selection

医生对IIIA期非小细胞肺癌患者的治疗偏好：淋巴结转移程度对治疗选择的影响

期刊:Journal of Thoracic Oncology
影响因子:20.8
doi:10.1097/JTO.0b013e31823a385f
Tanner, Nichole T; Gomez, Mario; Rainwater, Chelsea; Nietert, Paul J; Simon, George R; Green, Mark R; Silvestri, Gerard A
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2012
文献求助 收藏

Cisplatin, irinotecan, and bevacizumab for untreated extensive-stage small-cell lung cancer: CALGB 30306, a phase II study.

顺铂、伊立替康和贝伐单抗治疗未经治疗的广泛期小细胞肺癌：CALGB 30306，一项 II 期研究

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.2011.35.6923
Ready Neal E, Dudek Arkadiusz Z, Pang Herbert H, Hodgson Lydia D, Graziano Stephen L, Green Mark R, Vokes Everett E
细胞生物学
肺癌
肿瘤免疫
发表日期：2011
文献求助 收藏

Phase I study of accelerated conformal radiotherapy for stage I non-small-cell lung cancer in patients with pulmonary dysfunction: CALGB 39904

一项针对肺功能障碍患者的I期非小细胞肺癌加速适形放射治疗的I期研究：CALGB 39904

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.2009.25.0753
Bogart, Jeffrey A; Hodgson, Lydia; Seagren, Stephen L; Blackstock, A William; Wang, Xiaofei; Lenox, Robert; Turrisi, Andrew T 3rd; Reilly, John; Gajra, Ajeet; Vokes, Everett E; Green, Mark R
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2010
文献求助 收藏

Prognostic significance of mucin and p53 expression in stage IB non-small cell lung cancer: a laboratory companion study to CALGB 9633

黏蛋白和p53表达在IB期非小细胞肺癌中的预后意义：CALGB 9633的实验室伴随研究

期刊:Journal of Thoracic Oncology
影响因子:20.8
doi:10.1097/jto.0b013e3181d89f95
Graziano, Stephen L; Gu, Lin; Wang, Xiaofei; Tatum, Arthur H; Vollmer, Robin T; Strauss, Gary M; Kratzke, Robert; Dudek, Arkadiusz Z; Vokes, Everett E; Green, Mark R
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2010
文献求助 收藏

Treatment outcomes of different prognostic groups of patients on cancer and leukemia group B trial 39801: induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for unresectable stage III non-small cell lung cancer

癌症和白血病B组39801试验中不同预后组患者的治疗结果：诱导化疗后序贯放化疗与单纯放化疗治疗不可切除的III期非小细胞肺癌的比较

期刊:Journal of Thoracic Oncology
影响因子:20.8
doi:10.1097/JTO.0b013e3181b27b33
Stinchcombe, Thomas E; Hodgson, Lydia; Herndon, James E 2nd; Kelley, Michael J; Cicchetti, M Giulia; Ramnath, Nithya; Niell, Harvey B; Atkins, James N; Akerley, Wallace; Green, Mark R; Vokes, Everett E
肺癌
肿瘤
肿瘤免疫
白血病
细胞生物学
发表日期：2009
文献求助 收藏

Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups

辅助性紫杉醇加卡铂治疗与观察治疗在IB期非小细胞肺癌中的比较：CALGB 9633，由癌症和白血病B组、放射治疗肿瘤组和北中部癌症治疗组研究组开展

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.2008.16.4855
Strauss, Gary M; Herndon, James E 2nd; Maddaus, Michael A; Johnstone, David W; Johnson, Elizabeth A; Harpole, David H; Gillenwater, Heidi H; Watson, Dorothy M; Sugarbaker, David J; Schilsky, Richard L; Vokes, Everett E; Green, Mark R
肺癌
肿瘤
肿瘤免疫
白血病
细胞生物学
发表日期：2008
文献求助 收藏

Phase II trial of paclitaxel and cisplatin in patients with extensive stage small cell lung cancer: Cancer and Leukemia Group B Trial 9430

紫杉醇和顺铂治疗广泛期小细胞肺癌患者的II期试验：癌症和白血病B组9430试验

期刊:Journal of Thoracic Oncology
影响因子:20.8
doi:10.1097/JTO.0b013e318187494a
Stinchcombe, Thomas E; Mauer, Ann M; Hodgson, Lydia D; Herndon, James E 2nd; Lynch, Thomas J; Green, Mark R; Vokes, Everett E
肺癌
肿瘤
肿瘤免疫
白血病
细胞生物学
发表日期：2008
文献求助 收藏

Tomorrow's cancer treatments today: the first 50 years of the Cancer and Leukemia Group B

今日成就明日癌症治疗：癌症和白血病B组成立50周年

期刊:Seminars in Oncology
影响因子:2.5
doi:10.1053/j.seminoncol.2008.07.002
Green, Mark R; George, Stephen L; Schilsky, Richard L
白血病
肿瘤
肿瘤免疫
发表日期：2008
文献求助 收藏

Adjuvant Therapy Choices in Patients With Resected Non-Small-Cell Lung Cancer: Correlation of Doctors' Treatment Plans and Relevant Phase III Trial Data

接受手术切除的非小细胞肺癌患者的辅助治疗选择：医生治疗方案与相关III期临床试验数据的相关性

期刊:Journal of Oncology Practice
影响因子:
doi:10.1200/JOP.2005.1.2.37
Green, Mark R; Andrews, Michele; Leff, Richard; Willey, Joanne; Allegra, Carmen; Denes, Alex; Epstein, James; Jones, James; Lokey, Lee
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2005
文献求助 收藏